INVERNESS MEDICAL INNOVATIONS, INC., as Issuer, and U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 12, 2009Indenture • May 12th, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
INDENTURE dated as of May 12, 2009 between Inverness Medical Innovations, Inc., a Delaware corporation, as Issuer (the “Issuer”), and U.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee”).
INVERNESS MEDICAL INNOVATIONS, INC., as Issuer, the GUARANTORS named herein, as Guarantors, and U.S. BANK NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of May 12, 2009 9.00% Senior Subordinated Notes due 2016First Supplemental Indenture • May 12th, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of May 12, 2009 (this “Supplemental Indenture”), among Inverness Medical Innovations, Inc., a Delaware corporation, as Issuer (the “Issuer”), each of the Guarantors named herein, as Guarantors, and U.S. Bank National Association, a national banking association, as Trustee (the “Trustee”).
Inverness Medical Innovations, Inc. $400,000,000 9.00% Senior Subordinated Notes due 2016 UNDERWRITING AGREEMENTUnderwriting Agreement • May 12th, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
UBS SECURITIES LLC GOLDMAN, SACHS & CO. BANC OF AMERICA SECURITIES LLC As Representatives of the several Underwriters c/o UBS SECURITIES LLC 299 Park Avenue New York, New York 10171
